Life Sciences

Global Leaders in Life Sciences
  • Access to Capital - $6.5 billion of equity capital raised in 2015
  • Liquid Trading Market - More than 5.3 billion shares were traded in 2015
  • Analyst Coverage - Four out of five TSX listed Life Sciences companies are covered by an analyst
  • Tailored & Flexible Listing Criteria - Listing criteria focuses on evidence of adequate financing and operational expertise to carry the company forward with its intended development program
  • Growth Potential - TSXV Issuers can graduate to TSX as the company fulfills its growth strategy

Sector Activity at a Glance – YTD November 30, 2016

November 2016TSXVTSXTSXV and TSX
Number of Issuers 83 44 127
QMV (C$) 3,355,143,374 21,073,739,762 24,428,883,136
New Listings 11 4 15
Equity Capital Raised (C$) 200,706,389 528,221,773 728,928,162
Number of Financings 65 31 96
Volume Traded 2,710,143,633 2,973,077,776 5,683,221,409
Value Traded (C$) 3,051,516,777 22,420,073,502 25,471,590,278
# of Trades 1,050,514 4,859,470 5,909,983

Sector Information

For more information on Toronto Stock Exchange and TSX Venture Exchange listed companies, please refer to our Current Market Statistics.

Indices

S&P/TSX Capped Health Care Index

Information

To learn more about listing in the Life Sciences sector on TSX/TSXV, please contact:

Michael Kousaie
Head, Business Development, Life Sciences
+1 416 947-6626
michael.kousaie@tsx.com

Business Development - Asia
(86) 1065 05 8011
asia@tsx.com

Business Development - Europe & Africa
emea@tsx.com

Follow us on Twitter: @tsx_tsxv

v x